Management of Cytomegalovirus Infection in Haemopoietic Stem Cell Transplantation

This is a clinical practice guideline for patients with cytomegalovirus (CMV) infection in haemopoietic stem cell transplantation. The guideline reviews risk factors and diagnostic assessment of CMV infection and disease, impact of host and donor CMV serostatus, prevention of CMV disease occurrence, primary prophylaxis for CMV, pre-emptive therapy, and management of CMV disease. Outcomes of interest include risk factors of CMV infection, sensitivity of diagnostic tests, efficacy of treatment, and toxicity.